Objective: An electrochemical method, based on anodic oxidation and/or protolysis, has been developed with the aim of extending it to the dissolution of urinary stones. The method has been named electrolitholysis, or ELLYS. An ex vivo experimental trial has been performed to check the current intensity needed to obtain the dissolution of stones without lesions to tissues. A new therapeutic method has been conceived based on these preliminary findings. Materials and Methods: An ex vivo experimental trial has been performed on twelve bladders surgically removed from pigs and placed in an experimental model resembling possible vital organs; the electrolytic dissolution of natural urinary stones was then performed in these bladders. Results: The ex vivo trial showed that the method is safe and reliable if the current intensity is maintained at ≤30 mA. Conclusions: A new therapy based on a new concept has been conceived which can be delivered percutaneously through an electrified spiral stent implanted several days into renal cavities and connected with a power supplier (battery) attached to the patient’s flank.

Keywords:
Electrolitholysis, Anodic oxidation, Continuous current, Current intensity, Spiral stent
This content is only available via PDF.
© 2004 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.